PharmaCyte Biotech, Inc. (PMCB): EPS (Basic)

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2012-04-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$2.77

Year ended 2026-04-30

2011-04-30 EPS (Basic) (USD per share) 2026-04-30

Period ended	EPS (Basic)	Change YoY	Source filing
2026-04-30	-$2.77	n/m	2026-07-29, From 2025-05-01
2025-04-30	$3.19	n/m	2026-07-29, From 2024-05-01
2024-04-30	-$1.80	n/m	2025-08-11, From 2023-05-01
2023-04-30	-$0.22	n/m	2024-08-13, From 2022-05-01
2022-04-30	-$0.27	n/m	2023-07-31, From 2021-05-01
2021-04-30	-$2.45	n/a	2022-07-28, From 2020-05-01
No annual figure between 2014-04-30 and 2021-04-30.
2014-04-30	-$0.05	n/a	2014-08-04, From 2013-05-01
2013-04-30	$0.00	n/m	2014-08-04, From 2012-05-01
2012-04-30	-$0.01	n/c	2013-07-29, From 2011-05-01
2011-04-30	$0.00	n/a	2012-08-14, From 2010-05-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EPS (Basic)	Change YoY
PharmaCyte Biotech, Inc. (PMCB)	2026-04-30	-$2.77	n/m
Vaxart, Inc. (VXRT)	2025-12-31	$0.07	n/m
Amgen Inc (AMGN)	2025-12-31	$14.33	+88.1%
Repligen Corp (RGEN)	2025-12-31	$0.87	n/m
Champions Oncology, Inc. (CSBR)	2026-04-30	-$0.08	n/m
Bio-Techne Corp (TECH)	2026-06-30	$1.17	+148.9%
Biogen Inc. (BIIB)	2025-12-31	$8.83	-21.2%
Lineage Cell Therapeutics, Inc. (LCTX)	2025-12-31	-$0.28	n/m
Gilead Sciences, Inc. (GILD)	2025-12-31	$6.84	n/m

Compare PMCB, VXRT, AMGN, RGEN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗